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Abstract
Background: Morbidity plays an important role in the development of and recovery from malnutrition. Morbidity
in children with moderate acute malnutrition (MAM) has not been described in detail and it is unclear how
morbidity compares to serum levels of acute phase proteins (APPs) which indicate systemic inflammation and
which can impede response to therapeutic nutritional interventions. The objective of this study was to describe
morbidity in children with MAM and to assess to what extent maternally reported and clinically diagnosed
morbidity explain the variation in APPs.
Methods: A cross-sectional sub study was conducted as part of a nutrition intervention trial among 6–23 months
old children with MAM residing in Burkina Faso. Morbidity data collection at baseline included 2 week maternal
recalls and physical examinations. Multivariate ANCOVA models were used to explore the associations between
morbidity and C-reactive protein (CRP) as well as α1-acid glycoprotein (AGP). These models were also used to
determine to what extent morbidity explains variation in APPs.
Results: In the 2 weeks prior to the study inclusion visit, 38 % of children were ill according to mothers.
Furthermore, 71.8 % of children had a symptom or infection identified during the physical examination and 24.2
and 66.4 % of children had elevated CRP and AGP, respectively. Among children without any identified symptom
or illness at the inclusion visit, 10.7 and 46.5 % had elevated CRP and AGP, respectively. History of fever as well as
nurse-documented fever, malaria, respiratory tract infections and skin infections were associated with higher levels
of both APPs. History of cough and diarrhoea at the inclusion visit was associated with higher α1-acid glycoprotein
only. Overall, morbidity data only explained a small amount of the variation in APP levels (adjusted R2 below 0.2 in
all tested models).
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Conclusion: Morbidity among children with MAM in this setting is common, but maternal reports and clinical
examination explained only a small proportion of the variation in APPs, indicating a presence of subclinical
inflammation. We recommend further research into the causes of this subclinical inflammation as it could affect
nutritional status and success of MAM treatment.
Trial registration: The trial was registered in the International Standard Randomised Controlled Trial Number
Register (ISRCTN42569496).
Keywords: Moderate acute malnutrition, Morbidity, Inflammation, Acute phase proteins, Children
Abbreviations: AGP, α1-acid glycoprotein; ANCOVA, Analysis of covariance; CRP, C-reactive protein; HRP2, Histidine-
rich protein 2; IMCI, Integrated Management of Childhood Illness; LRTI, Lower respiratory tract infection;
MAM, Moderate acute malnutrition; MUAC, Mid-upper-arm-circumference; RDT, Rapid diagnostic test; WHZ, Weight-
for-height z-score
Background
Moderate wasting, defined as a weight-for-height z-
score (WHZ) between -2 and -3, affects approximately
33 million children worldwide [1] and is associated with
a higher risk of death from infectious diseases compared
to children without anthropometric deficits [2].
Malnutrition interacts with infections in a vicious cycle
whereby it not only increases the risk and severity of in-
fections, but can also be a result of infection [3]. Early
diagnosis and treatment of infections in malnourished
children is therefore required, in addition to nutritional
treatment, to break this cycle. Morbidity is assessed via a
combination of subjective and objective findings through
history-taking (relying on recall by the caretaker) and a
physical examination carried out by a health professional.
In addition, measurement of serum acute phase proteins
such as C-reactive protein (CRP) and alpha-1 acid glyco-
protein (AGP) can provide objective information about
inflammation but are rarely measured in low resource set-
tings. Acute phase proteins rise or fall in response to
infection or injury but are not specific to any particular
disease [4]. Asymptomatic children can have elevated
levels of acute phase proteins [5, 6] indicating the presence
of subclinical inflammation, due to conditions that are not
captured by patient history or physical examination. In-
flammation can affect nutrient intake, nutrient absorption
and expenditure [7, 8] and may therefore also play a role in
effectiveness of nutrient supplements provided to treat
malnutrition and nutrient deficiency disease.
Few studies have reported on morbidity in children
with moderate wasting or moderate acute malnutrition
(MAM) [9–15] and most based only on symptom-recall.
Current case definitions of MAM includes children with
moderate wasting and/or a mid-upper arm circumfer-
ence (MUAC) between 115 and 125 mm [16]. Further-
more, to our knowledge none have compared morbidity
data from maternal recall and physical examination to
markers of inflammation in children with MAM.
As part of a nutrition intervention trial, we aimed to
describe morbidity and inflammation in children with
MAM and to assess to what extent morbidity by maternal
recall and physical examination explains the variation in
markers of inflammation.
Methods
Study area and population
The data for this observational study were collected as
part the TreatFOOD trial, a randomised controlled trial
investigating effectiveness of six corn-soy blends and six
lipid-based nutrient supplements in treating MAM
carried out in the Passoré Province, Northern Region,
Burkina Faso. This part of Burkina Faso is located in the
Sudano-sahelian zone which is characterised by an
average yearly rainfall of 600–700 mm [17]. The year is
divided into one dry and one rainy season, where the
latter runs from approximately mid-May to late October
[18]. The catchment area covered a total of 143 villages
and a total population of ~258,000.
Children aged 6–23 months with MAM resident in the
catchment area and whose parents/guardians consented
to participate were included. Screening for participants
was carried out by community health workers using
MUAC tapes or by designated screening teams using both
MUAC and WHZ. In addition, children could be referred
from a health centre or could present at site on caretaker’s
initiative. Recruitment took place from September 2013
until August 2014.
Data collection
Socio-demographic data were collected by trained inter-
viewers. Weight was measured in duplicate to the nearest
100 g with an electronic scale (Seca model 881 1021659).
Length was measured in duplicate with a wooden length
board to the nearest 1 mm. MUAC was measured to the
nearest 1 mm using a standard measuring tape. Morbidity
data collection included a patient history based on 14-day
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maternal recall of symptoms and a physical examination
carried out by study nurses. Study nurses were trained
and supervised by a study physician. 2.5 ml of venous
blood were collected from the arm. One drop of blood
was used for diagnosis of malaria on site using a rapid
diagnostic test (RDT) that detects histidine rich protein 2
(HRP2) synthesized by the Plasmodium falciparum mal-
aria parasite (Bioline, Malaria Ag P.f, Standard diagnostics
Inc.). The remaining blood from each sample was put into
a sample tube with clot activator (BD reference #368492)
and transported to the trial laboratory in a cold box at
2–8 °C. Serum was isolated following centrifugation at
3000 RPM for 5 min (EBA 20 S Hettich) and stored at
-20 °C until shipment to VitMin Lab in Willstaedt,
Germany for analysis. Serum CRP and AGP were deter-
mined using a simple sandwich enzyme-linked im-
munosorbent assay [19]. All samples were measured in
duplicate and the intra- and interassay co-efficients of
variation were <10 %. Freeze-thaw cycles were avoided
during the handling of all samples.
Fever was defined as an axillary temperature ≥ 37.5 °C.
Upper and lower respiratory tract infections were diag-
nosed by experienced nurses based on an adapted version
of the Integrated Management of Childhood Illnesses
(IMCI) guidelines. Diarrhoea was defined as three or more
loose watery stools per day based on information provided
by the mother. Malaria diagnosis was based on a positive
rapid diagnostic test (RDT) only, and no microscopy was
done to establish the level of parasitaemia. Since HRP2,
the protein detected by the RDT, can persist in blood for
over a month after treatment of malaria [20, 21] positive
RDT in absence of clinical findings may be due to either a
treated infection or asymptomatic malaria. We therefore
present prevalence of children with a positive RDTaccom-
panied by fever in addition to prevalence of positive RDT
independent of fever. The thresholds used for defining ele-
vated acute phase protein levels were CRP >10 mg/l [4]
and AGP >1 g/l [8].
Two binary composite morbidity variables were gener-
ated based on maternal recall and physical examination
data. A child was considered ill according to maternal
recall if the caretaker reported that their child had, in
the previous 2 weeks, any of the following: fever, cough,
diarrhoea, vomiting, breathing problems, reduced appe-
tite, rash, pain or swelling. A child was considered ill ac-
cording to physical examination if he/she had one or
more of the following: skin problem (rash, ulcer, infec-
tion or other), respiratory tract infections, ear infection,
diarrhoea, oral thrush, mouth ulcer, fever and malaria.
These two variables were combined to generate 4 illness
groups, that is i) no symptom/illness identified, ii) ill
according to maternal recall only, iii) ill according to
physical examination only, iv) ill according to maternal
recall and physical examination.
Data handling and statistical analysis
Data were double entered into EPIDATA 3.1 Software
(Epidata Association, Odense, Denmark) and double entry
checks were performed on a daily basis. All statistical ana-
lyses were carried out using STATA version 12 (StataCorp,
College Station TX, USA). P-values <0.05 were considered
significant.
Baseline characteristics as well as symptoms and ill-
nesses were summarised as percentage, mean (SD), or me-
dian (interquartile range). Logistic regression was used to
investigate whether morbidity (symptoms and illnesses
according to both mother and nurse as well as inflam-
mation) differed according to admission category (low
MUAC only, low MUAC and low WHZ or low WHZ
only). The models were adjusted for age and sex.
Analysis of covariance (ANCOVA) was used to evalu-
ate differences in mean CRP and AGP levels between
illness groups by means of pairwise comparisons while
adjusting for age and sex. ANCOVA, in univariate and
multivariate models, was used to explore the associa-
tions between acute phase protein concentrations and
presence of illnesses and to determine the amount of
variation in acute phase proteins explained by morbidity
data. Six multivariate models were built: two with data
from maternal recalls as predictor, two with data from
physical examinations and two with data from both
sources as predictors and with either CRP or AGP as
outcome. All models were adjusted for age and sex. Log
transformations were applied to achieve normally dis-
tributed variables, if needed, and estimates were subse-
quently back-transformed [22]. Models were checked
using residual and normal probability plots.
Results
Of the 1609 enrolled children 29 % of children were
admitted based on MUAC only, 50 % based on MUAC
and WHZ and 21 % based on WHZ only as reported
previously [23]. Over half (54.6 %) of participants were
female. Prevalence of stunting (height-for-age < -2) was
37.7 %. The mean (SD) age was 12.3 (4.8) months
(Table 1). Age differed between admission categories,
more specifically it was 11 (4.6), 12.6 (4.8) and 13.7 (4.8)
months in children admitted based MUAC only, MUAC
and WFH and WFH only (p < 0.001). Admission cat-
egories are presented in order of increasing age for the
remainder of this paper. Mothers reported illnesses in
the 2 week period prior to admission in 38 % of children.
According to the physical examination by the study
nurse 71.8 % of children were ill and/or had a positive
malaria test on the day of the visit (Table 2). The most
prevalent illnesses diagnosed by the nurse were malaria
based on positive RDT (40.2 %), lower respiratory tract in-
fections (23.2 %) and upper respiratory tract infections
(14.6 %). Fever (without a source on clinical examination)
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was also common (17.7 %). Fever was more common in
children with a positive malaria rapid test than those
without (21.0 % vs 15.6 %, p = 0.006). 31.8 % (n = 509) had
a positive RDT but no fever and 20.5 % (n = 329) had a
positive RDT but no other clinical symptoms. Almost a
quarter (24.2 %) and two thirds (66.4 %) of children had
serum CRP >10 mg/l and serum AGP >1 g/l, respectively
(Table 2.). Positive malaria RDTs were more common
among children admitted based on MUAC only than chil-
dren admitted based MUAC and WHZ or WHZ only after
adjustment for age and sex. More children had lower
respiratory tract infection if they were admitted based on
only WHZ compared to only MUAC or MUAC and
WHZ after adjustment for age and sex. There was no as-
sociation between other symptoms, illnesses and acute
phase protein levels and admission categories (Table 2).
There was a considerable overlap of children who were
ill based on maternal recall, physical examination and el-
evated acute phase proteins (Fig. 1); however, only 10 %
of children for CRP and 24 % for AGP were ill according
to all three measures. Among the total study population
2 and 10 % had serum CRP >10 mg/l and AGP >1 g/l,
respectively, in the absence of any reported illnesses or
symptoms according to the mother and/or the nurse
(Fig. 1). A total of 338 (20.8 %) children had no identi-
fied symptoms or illnesses according to either maternal
recall or physical examination whereas only 302 children
(19 %) had normal CRP and 181 children (12 %) had
normal AGP in the absence of symptoms. Therefore, of
asymptomatic children, 10.7 % (n = 36) and 46.5 % (n =
157) had a CRP >10 mg/l and AGP >1 g/l, respectively.
Mean serum CRP and AGP were higher in children who
were ill according to both mother and nurse compared
to those who were ill according to the nurse only (p <
0.05) (Table 3.). These results remained significant if
children with a positive malaria test in the absence of
fever were not considered to be ill according to the
nurse (data not shown).
The estimates shown in Table 4 correspond to the dif-
ference in acute phase protein means between those
who had and those who did not have a particular symp-
tom for the two univariate and two multivariate models.
Overall, children who had been ill according to either
the study nurse and/or maternal recall had a 2.7 mg/l (p
< 0.001) and 0.33 g/l (p < 0.001) higher mean serum CRP
and AGP, respectively, compared to those without any
reported symptoms.
In univariate models, history of fever and cough were
associated with higher serum AGP and CRP; diarrhoea
and vomiting were not. In addition, fever, malaria and
skin infections diagnosed by the nurse were associated
with higher serum CRP and AGP. Lower respiratory
tract infection and ear infection were associated with
serum AGP but not CRP (Table 4). Differences in means
ranged from 1.4 mg/l for skin infections (p < 0.001) to
2.86 mg/l (p < 0.001) for fever for CRP and from 0.11 g/l
for lower respiratory tract infection (p < 0.001) to 0.31 g/
l (p < 0.001) for positive malaria test for AGP (Table 4).
Children with malaria but no fever had a 2.8 mg/l and
0.3 g/l higher mean CRP and AGP, respectively, than
children without malaria or fever (p < 0.001), whereas
children with malaria and fever had a 5.9 mg/l and
0.6 g/L higher mean CRP and AGP, compared to chil-
dren without malaria or fever (p < 0.001). In multivariate
models, the association between history of cough and
serum CRP was lost and history of vomiting became as-
sociated with a lower CRP. Diarrhoea on the day of ad-
mission and upper respiratory tract infection became
associated with serum AGP and both upper and lower
respiratory tract infection became associated with serum
CRP (Table 4). The adjusted R2 for serum CRP using
morbidity data from maternal recall and physical exam-
ination was 0.053 and 0.112, respectively (Table 4) and
increased to 0.141 if data from maternal recall and phys-
ical examination were included in the same model. The
adjusted R2 for serum AGP using morbidity data from
maternal recall and physical examination was 0.103 and
0.152, respectively (Table 4) and increased to 0.186 if
Table 1 Background characteristics of 1609 6–23 months old
children with moderate acute malnutrition
Sex, % female (n) 54.6 (879)
Age, months mean (SD) 12.3 (4.8)
Inclusion category, % (n)
Low mid-upper-arm circumference only 29 (468)
Low weight-for-height z-score and low
mid-upper arm circumference
50 (804)
Low weight-for-height z-score only 21 (337)
Height-for-age z-score < -2, % (n) 37.7 (607)
Mother’s education levela, % (n)
None 85.5 (1374)
Primary incomplete 7.9 (127)
Primary complete or higher 6.3 (102)
Mother’s professiona, % (n)
Agriculture 94.3 (1516)
Animal farming 1.6 (25)
Other 4.1 (67)
Mother’s ethnic groupa, % (n)
Mossi 94.1 (1512)
Peulh/Fulani 2.3 (37)
Other 3.6 (58)
Household size, median (interquartile range) 10 (7–16)
Number of children under 5 y in the household, median
(interquartile range)
2 (2–4)
aMissing data: ethnic group (n = 1), education level (n = 5), profession (n = 2)
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data from maternal recall and physical examination were
included in the same model.
Discussion
In this cross-sectional study we have shown that infections
and inflammation in children with MAM are common
and largely independent of admission criteria. We have
also shown that symptoms and illnesses identified by
mothers and by nurses during physical examinations are
associated with serum APP levels but that morbidity only
explains a small amount of variation in APPs and that
even children without any identified symptoms can have
elevated APP levels.
This study had a number of limitations. Firstly, the data
used were baseline data collected for a randomised con-
trolled trial and data collection was thus not specifically
designed for this study. As a result we had no control
group and have not been able to compare prevalence of
infection and inflammation to children without anthropo-
metric deficits in the same setting. Furthermore, inclusion
in the study was based on active case finding by commu-
nity health workers and study staff or based on mother’s
initiative and not based on random selection among all
children with MAM in catchment area. As such, selection
bias cannot be ruled out, which may have led to overesti-
mation of the prevalence of morbidity, since sick children
are more likely to have been selected. A further limitation
may be the accuracy of lower respiratory tract infection
(LRTI) diagnosis by nurses as diagnosis has previously
been shown to be unreliable other settings [24, 25]. It is
worth mentioning also that although the immune
response is altered by malnutrition, a recent review on
the immune system in malnourished children con-
cluded that the acute phase response appears intact [6]
Table 2 Prevalence of symptoms and illnesses according to maternal recall and physical examination by admission criteria
All Low Mid-upper arm
circumference (MUAC)
Low MUAC and low
weight-for-height z-score (WHZ)
Low WHZ p-value
Maternal recalla, % (n)
Any symptom 38.0 (608) 34.6 (161) 39.1 (312) 40.2 (135) 0.5
Fever 20 (322) 17.8 (83) 20.3 (162) 22.9 (77) 0.8
Diarrhoea 17.9 (286) 14.8 (69) 19.8 (158) 17.6 (59) 0.9
Cough 9.6 (153) 7.9 (37) 9.5 (76) 11.9 (40) 0.1
Vomiting 6.8 (109) 4.7 (22) 7.4 (59) 8.3 (28) 0.2
Skin infections 0.5 (8) 0.4 (2) 0.5 (4) 0.6 (2) 0.9
Loss of appetite 0.1 (2) 0 (0) 0.1 (1) 0.3 (1) 0.4
Physical examinationa, % (n)
Any symptom 71.8 (1155) 72.6 (340) 71.9 (578) 74.2 (250) 0.5
Fever 17.7 (285) 15.6 (73) 17.3 (139) 21.7 (73) 0.1
Positive malaria test 40.2 (644) 46 (214) 38.8 (310) 35.6 (120) <0.001
Without fever 31.8 (509) 38.4 (178) 30.7 (245) 25.6 (86) <0.001
With fever 8.4 (135) 7.8 (36) 8.1 (65) 10.1 (34) 0.8
Upper respiratory tract infection 14.6 (234) 13.5 (63) 15.8 (127) 13.1 (44) 0.3
Lower respiratory tract infection 23.2 (373) 20.5 (96) 22.4 (180) 28.8 (97) 0.006
Diarrhoea 5.8 (94) 5.1 (23) 6 (48) 6.5 (22) 0.9
Skinb 3.9 (63) 4.5 (21) 3.7 (30) 3.6 (12) 0.6
Earc 1.1 (17) 1.1 (5) 0.9 (7) 1.5 (5) 0.7
Acute phase proteinsa
Serum C-reactive protein, mg/l,
Median (interquartile range) 2.3 (0.8–9.4)
> 10 mg/L, % (n) 24.2 (378) 22.7 (103) 24.2 (190) 26.1 (85) 0.06
Serum α1-acid glycoprotein, g/l,
Median (interquartile range) 1.2 (0.9–1.6)
> 1 g/L, % (n) 66.4 (1039) 62.6 (284) 69.4 (544) 64.7 (211) 0.6
aMissing data: Maternal recall all symptoms (n = 9), fever (n = 1), malaria (n = 8), Upper respiratory tract infection (n = 2), lower respiratory tract infection (n = 1),
skin infections (n = 3), ear infections (n = 2), acute phase proteins (n = 45)
bincludes rash, infections, ulcer
cincludes discharge, pain and other
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and we therefore believe that CRP and AGP provide
useful information about inflammation in children with
MAM.
Our study demonstrates several important points.
First, overall more than 80 % of children had an infec-
tion and/or inflammation. Considering the interaction
between infection and nutrition, treatment of infections
may therefore be important as part of MAM treatment
in this setting. In Burkina Faso MAM treatment consists
mainly of supplementary food and routine medication
including deworming and Vitamin A and iron folic acid
supplementation. Treatment of asymptomtic malaria is
not recommended and little emphasis is placed on iden-
tification and treatment of infection [26].
Second, information provided by mothers on children’s
health status as well as diagnoses made during physical
examination appear to be reliable as demonstrated by
the association between symptoms and APP levels.
Although, as mentioned above there is some concern
about reliability of LRTI diagnosis. While data from
maternal recall explain less of the variation in APPs than
data from physical examinations, both methods are
useful and the information they provide is complemen-
tary as is also indicated by the higher adjusted R2 in the
models where data from both sources were included.
The two acute phase proteins we measured have differ-
ent properties: CRP responds to infection quickly and
reaches its maximum within 24–48 h and drops shortly
after while AGP reaches a maximum concentration after
2–5 days and stays elevated longer [27]. It is therefore
not surprising that morbidity data explains more of the
variation in AGP than CRP. Furthermore, illnesses re-
ported by mothers could have occurred 14 days in the
past by which time APPs could have returned back to
normal levels which may partly explain why the R2 for
models using recall data is lower than that for models
using data from physical examinations. That mothers
reported less illness than nurses might be in part due to
accuracy of recall data being affected by reporting and
recall bias [28, 29], perception of an abnormal situation,
or tolerance to discomfort [30]. The latter is likely to be
a cause of underreporting in a population such as this
one where disease is common and even more so if proxy
reporting is used as children may start feeling unwell
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Fig. 1 Overlap between children ill according to maternal recall, physical examination and elevated acute phase proteins. a C-reactive protein >
10 mg/l; b α1-acid glycoprotein >1 g/l. ___ Any symptom/illness according to physical examination. _ _ _ Any sympton/illness according to maternal
recall.…… Elevated acute phase protein. 1 Percentage of children without illness or inflammation; 2 % ill according to maternal recall (MR) only; 3 %
with inflammation and ill according MR; 4 % ill according to physical examination (PE) and MR; 5% with inflammation and ill according to PE and MR;
6% with inflammation and ill according to PE; 7 % with inflammation only; 8 % ill according to PE only
Table 3 Mean acute phase protein levels by illness group
% (n) Mean level of C-reactive protein mg/l
(95 % confidence intervals) a,b
Mean α1-acid glycoprotein g/l
(95 % confidence intervals) a,b
Not ill 21.6 % (345) 1.24 (1.03–1.5) 0.97 (0.92–1.01)
Ill according to mother only 6.6 % (105) 1.68 (1.2–2.35) 1.13 (1.04–1.23)
Ill according to mother and nurse 31.4 % (503) 3.91 (3.35–4.57) 1.4 (1.35–1.46)
Ill according to nurse only 40.4 % (647) 3.1 (2.71–3.55) 1.25 (1.21–1.29)
aMeans are geometric means
bPairwise comparisons between means adjusted for age and sex showed no significant difference for mean CRP level between children who were not ill and those who
were ill according to mother only. All other pairwise comparisons were significant (p < 0.05)
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Table 4 Morbidity by maternal recall and examination as correlates of serum acute phase proteins
Serum C-reactive proteind (mg/l) Serum α1-acid glycoprotein (g/l)
Univariate modelf Multivariate modelf,g Univariate model Multivariate modelf,h
Estimate (95 % confidence
interval)e
p-value Estimate (95 % confidence
interval)e
p-value Estimate (95 % confidence
interval)e
p-value Estimate (95 % confidence
interval)e
p-value
Maternal recalla
Any symptom 1.09 (0.59–1.58) <0.001 0.21 (0.15–0.26) <0.001
Fever 2.68 (2.05–3.31) <0.001 2.93 (2.26–3.62) <0.001 0.33 (0.26–0.40) <0.001 0.30 (0.23–0.38) <0.001
Diarrhoea -0.26 (-0.88-0.35) 0.4 -0.59 (-1.30 -0.13) 0.1 0.05 (-0.02-0.13) 0.1 -0.002 (-0.08–0.07) 0.9
Cough 1.36 (0.55-2.17) 0.001 0.53 (-0.36-1.43 0.2 0.27 (0.18–0.36) <0.001 0.17 (0.07- 0.26) 0.001
Vomiting -0.74 (-1.69-0.22) 0.1 -1.53 (-2.65- -0.42) 0.007 0.06 (-0.06-0.17) 0.3 -0.06 (-0.17- 0.06) 0.4
Physical examinationa
Any symptom 2.68 (2.13–3.22) <0.001 0.33 (0.27–0.39) <0.001
Fever 2.86 (2.20–3.52) <0.001 2.7 (2.06–3.50) <0.001 0.26 (0.19–0.33) <0.001 0.22 (0.15–0.29) <0.001
Positive malaria test 2.77 (2.25–3.29) <0.001 3.04 (2.47–3.61) <0.001 0.31 (0.26–0.37) <0.001 0.32 (0.26–0.38) <0.001
Upper respiratory tract
infection
0.6 (-0.07-1.3) 0.07 1.03 (0.23-1.82) 0.01 0.06 (-0.02-0.13) 0.1 0.08 (0.003-0.16) 0.04
Lower respiratory tract
infection
0.5 (-0.04-1.1) 0.07 0.67 (0.02–1.32) 0.04 0.1 (0.04–0.17) 0.002 0.16 (0.05–0.18) <0.001
Diarrhoea 0.12 (-0.89-1.12) 0.8 0.78 (-0.39-1.96) 0.2 0.07 (-0.05-0.19) 0.2 0.14 (0.03 -0.26) 0.01
Skinb 1.41 (0.20-2.62) 0. 02 1.64 (0.24-3.04) 0.02 0.15 (0.005-0.29) 0.04 0.14 (0.007-0.28) 0.04
Earc 1.75 (-0.58-4.08) 0.1 0.7 (-1.97-3.46) 0.6 0.34 (0.06-0.61) 0.02 0.22 (-0.04-0.49) 0.1
Physical examinationa & maternal recall
Any symptom 2.7 (2.09–3.31) <0.001 0.36 (0.29–0.42) <0.001
aMissing data: Maternal recall all symptoms (n = 9), fever (n = 1), malaria (n = 8), respiratory tract infection (n = 6), skin infections (n = 3), ear infections (n = 2)
bincludes rash, infections, ulcer
cincludes discharge, pain and other
dSince it is not possible to take a logarithm of zero, nine CRP values that were equal to zero were replaced with smallest number in the dataset, that is 0.01
eEstimates are back-transformed mean differences
fMultivariate models for maternal recall included fever, diarrhoea, cough and vomiting as predictors. Multivariate models for physical examination included fever, positive malaria test, respiratory tract infection,
diarrhoea, skin and ear infections as predictors. All models are adjusted for age and sex
gAdjusted R2 was 0.053 and 0.112 for the multivariate models using maternal recall data and physical examination data, respectively
hAdjusted R2 was 0.103 and 0.152 for the multiple regression using recall data and physical examination data, respectively
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before mothers notice it. In line with this, we found sig-
nificantly higher mean serum CRP and AGP levels
among children who were ill according to both nurses
and mothers compared to those ill according nurses
only. This may indicate that infections mothers bring to
the nurses attention are more severe than those identi-
fied by nurses only. 20 % of children had a positive mal-
aria test but no clinical signs or symptoms. While some
of these children may have already been successfully
treated for malaria, the higher serum CRP and AGP levels
in children with a positive RDT without fever indicate a
presence of asymptomatic malaria, which has previously
been shown to have health consequences [31].
Third, we have shown that, although morbidity was
largely independent of admission criteria, a positive RDT
not accompanied by fever was more common among
children admitted based on MUAC only and, in contrast,
lower respiratory tract infections were most common
among children admitted based on only low WHZ after
adjustment for age. Asymptomatic malaria in children
can persist for a long period of time [32] and we have
shown that even a positive RDT without fever is associ-
ated with a greater mean difference in APPs. It has been
suggested that since amino acid composition of APPs
differ from that of muscle, the amount of muscle mobi-
lised to make amino acids available for synthesis of APPs
may be quite substantial [33]. Asymptomatic malaria
may therefore lead to a greater breakdown of muscle
than LRTI and have a greater impact on MUAC. In
contrast a more acute condition such as LRTI may be
associated with lower WHZ resulting from a short term
impact of infection on weight due to anorexia and dehy-
dration. Dehydration has been shown to affect WHZ to
a greater extent than MUAC [34]. In addition there was
also a non significant trend for other conditions, such as
malaria accompanied by fever, to be more common in
children with low WFH.
Lastly, we have shown that elevated APP levels in chil-
dren without identified symptoms are not uncommon
and that morbidity data collected explained only a small
proportion of the variation, as demonstrated by the ad-
justed R2 which was <0.2 in all models, both indicating a
presence of subclinical inflammation. We have three
possible explanations for the low R2: Firstly, children
may have infections not identified by mothers or nurses
that might also have contributed to an increase in serum
CRP or AGP. Secondly, acute phase proteins may rise
during the incubation phase of a disease before clinical
symptoms become apparent and serum AGP remains
elevated during convalescence after an acute illness [8].
Thirdly, in addition to infection, there a range of other
conditions such as environmental enteric dysfunction
(EED), recent vaccinations, cooking with biomass fuels
and exposure to toxins that may elicit an acute phase
response [4, 8]. EED, previously known as environmental
enteropathy or tropical enteropathy, might play an im-
portant role as it is believed to be highly prevalent in
low-and middle income countries [35]. It is a usually
asymptomatic condition characterized by inflammation,
altered gut structure and function and is associated with
stunting in infants and children [35, 36]. It has been
hypothesised that EED may lead to systemic inflamma-
tion via increased intestinal permeability and microbial
translocation [37], and therefore may be one possible
cause of unexplained variation in biomarkers although
we did not carry out appropriate tests to determine
whether children had EED as part of this study.
Conclusion
Infections in children with MAM in this setting are
common and, in addition, children have inflammation
not explained by symptoms and illnesses identified
during patient histories or physical examinations. We
recommend further research to define the role of serum
APP in the diagnosis and treatment of childhood infec-
tions, into causes of this subclinical inflammation and
whether it has an impact on nutritional status and success
of MAM treatment.
Acknowledgements
We are grateful to the study participants and their families as well as the
study staff of the Alliance for International Medical Action (ALIMA) for
making this study possible. We furthermore thank the health and village
authorities in Province du Passoré, the staff at the health centres and the
Ministry of Health in Burkina Faso for their support to this study.
Funding
The study was funded by the Danish International Development Assistance
(09-097 LIFE), Médecins Sans Frontières (MSF Norway and MSF Denmark),
Arvid Nilssons Foundation and the World Food Programme (WFP), which
was part of a donation to WFP from a generous support of the American
people through the U.S. Agency for International Development’s Office of
Food for Peace (USAID) as well as the European Union’s humanitarian aid
funds, in partnership with Action Contre la Faim. This document covers
humanitarian aid activities implemented with the financial assistance of the
European Union. The views expressed herein should not be taken, in any
way, to reflect the official opinion of the European Union, and the European
Commission is not responsible for any use that can be made of the
information it contains.
Availability of data and materials
Data will be available upon request to the authors.
Authors’ contributions
BC, HF, CR conceptualized the study. BC, CF, CWY and RO conducted the
research; BC and CR analysed the data and BC wrote the first draft of the
manuscript; BC had primary responsibility for final content. CF, CWY, MR, CR,
AB, VC, KFM, RO, SF, PA, SS and HF revised the manuscript. All authors read
and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests. The funding
agencies had no role in the design of study, data collection and analysis, or
presentation of the results.
Ethics approval and consent to participate
The study was approved by the Ethics Committee in Burkina Faso and
consultative approval was obtained from the Danish National Committee
Cichon et al. BMC Nutrition  (2016) 2:57 Page 8 of 10
on Biomedical Research Ethics. Medical treatment was provided free of
charge according to an adapted version of the IMCI guidelines and
national protocol. Consent was obtained verbally and in writing (signature
or fingerprints) from parents or caretakers of the children before inclusion.
Caretakers of participants received an information sheet which was
explained to them. The information sheet and consent form were
translated into local language and back-translated to ensure accuracy. The
consent procedure was carried out in the presence of an independent
literate witness. Data were kept confidential and in a locked facility. The
trial was registered in the International Standard Randomised Controlled
Trial Number Register under the number ISRCTN42569496.
Author details
1Department of Nutrition, Exercise and Sports, University of Copenhagen,
Rolighedsvej 30, DK-1958 Frederiksberg C, Denmark. 2Médecins Sans
Frontières – Denmark, Dronningensgade 68, 3., 1420 Copenhagen, Denmark.
3Centre de Recherche en Sciences Biologiques, Alimentaires et
Nutritionnelles, UFR-SVT/University of Ouagadougou, 03 BP 7131
Ouagadougou, Burkina Faso. 4Institut de Recherche en Sciences de la Santé,
Ministère des Enseignements Supérieurs, de la Recherche Scientifique et de
l’Innovation, 03 BP 7192 Ouagadougou 03, Burkina Faso. 5Tampere Centre for
Child Health Research and Department for Paediatrics, University of Tampere
and Tampere University Hospital, Lääkärinkatu 1, 33014 Tampere, Finland.
6Department of Paediatrics, Righospitalet, Blegdamsvej 9, 2100 Copenhagen,
Denmark. 7The Alliance for International Medical Action (ALIMA), Route de
l’Aéroport, Rue NG 96, BP: 12000 Dakar, Sénégal. 8London School of Hygiene
and Tropical Medicine, Faculty of Epidemiology and Population Health,
Keppel Street, London WC1E 7HT, UK.
Received: 16 June 2016 Accepted: 16 August 2016
References
1. Black R, Victora C, Walker S, Bhutta Z, Christian P, de Onis M, et al. Maternal
and child undernutrition and overweight in low and middle income
countries. The Lancet. 2013;382:427–51.
2. Olofin I, McDonald C, Ezzati M, Flaxman S, Black R, Fawzi W, et al.
Associations of suboptimal growth with all-cause and cause-specific
mortality in children under five years: A pooled analysis of ten prospective
studies. PLoS One. 2013;8(5):e64636.
3. Katona P, Katona-Apte J. The Interaction between Nutrition and Infection.
Clin Infect Dis. 2008;46(10):1582–8.
4. Kushner I. Acute phase reactants. In: UpToDate [Internet]. Waltam, MA; 2015.
Available from: www.uptodate.com. Accessed 5 Feb 2016.
5. Filteau S, Morris SS, Abbott R, Tomkins A, Kirkwood B, Arthur P, et al.
Influence of morbidity on serum retinol of children in a community-based
study in northern Ghana. Am J Clin Nutr. 1993;58:192–7.
6. Rytter M, Kolte L, Briend A, Friis H, Christensen V. The immune system in
children with malnutrition—A systematic review. PLoS One. 2014;9(8):
e105017.
7. Jones K, Thitiri J, Ngari M, Berkley J. Childhood malnutrition: Toward an
understanding of infections, inflammation, and antimicrobials. Food Nutr
Bull. 2014;35:64–70.
8. Raiten D, Sakr Ashour F, Ross A, Meydani S, Dawson H, Stephenson C, et al.
Inflammation and Nutritional Science for Programs/Policies and Interpretation
of Research Evidence (INSPIRE). J Nutr. 2015;doi: 10.3945/jn.114.194571.
9. Nikiema L, Huybregts L, Kolsteren P, Lanou H, Tiendrebeogo S, Bouckaert K,
et al. Treating moderate acute malnutrition in first-line health services: an
effectiveness cluster-randomized trial in Burkina Faso. Am J Clin Nutr. 2014;
100:241–9.
10. LaGrone L, Trehan I, Meuli G, Wang R, Thakwalakwa C, Maleta K, et al. A
novel fortified blended flour, corn-soy blend “plus-plus”, is not inferior to
lipid-based ready-to-use supplementary foods for the treatment of
moderate acute malnutrition in Malawian children. Am J Clin Nutr.
2012;95:212–9.
11. Maust A, Koroma A, Abla C, Molokwu N, Ryan K, Singh L, et al. Severe and
moderate acute malnutrition can be successfully managed with an
integrated protocol in Sierra Leone. J Nutr. 2015;145:2604–9.
12. Usha Devi R, Krishnamurthy S, Vishnu BB. Epidemiological and clinical profile
of hospitalized children with moderate and severe acute malnutrition in
South India. Indian J Pediatr. 2015;82(6):504–10.
13. Ciliberto M, Sandige H, Nheka M, Ashorn P, Briend A, Ciliberto H, et al.
Comparison of home-based therapy with ready-to-use therapeutic food
with standard therapy in the treatment of malnourished Malawian children:
a controlled, clinical effectiveness trial. Am J Clin Nutr. 2005;81:864–70.
14. Ackatia-Armah R, McDonald C, Doumbia S, Erhardt J, Hamer D, Brown K.
Malian children with moderate acute malnutrition who are treated with
lipid-based dietary supplements have greater weight gains and recovery
rates than those treated with locally produced cereal-legume products:
a community-based, cluster-randomized trial. Am J Clin Nutr.
2015;101:632–45.
15. Stobaugh H, Ryan K, Kennedy J, Grise J, Crocker A, Thakwalakwa C, et al.
Including whey protein and whey permeate in ready-to-use supplementary
food improves recovery rates in children with moderate acute malnutrition:
a randomized, double-blind clinical trial. Am J Clin Nutr. 2016;doi: 10.3945/
ajcn.115.124636.
16. World Health Organisation. UNICEF, WFP and UNHCR consultation on the
programmatic aspects of the management of moderate acute malnutrition
in children under five years of age. Geneva: WHO; 2010.
17. FEWSnet. Livelihood zoning and profiling report: Burkina Faso. USAID; 2010.
18. FEWSnet. Burkina Faso Seasonal Calendar, typical year. [Internet]. 2013 [cited
2016 Jan 19]. Available from: http://www.fews.net/west-africa/burkina-faso.
Accessed 27 Aug 2016.
19. Erhardt J, Estes J, Pfeiffer C, Biesalsky H, Craft N. Combined Measurement of
Ferritin, Soluble Transferrin Receptor, Retinol Binding Protein, and C-Reactive
Protein by an Inexpensive, Sensitive, and Simple Sandwich Enzyme-Linked
Immunosorbent Assay Technique. J Nutr. 2004;134:3127–32.
20. Swarthout T, Counihan H, Senga R, Van den Broek I. Paracheck-Pf® accuracy
and recently treated Plasmodium falciparum infections: is there a risk of
over-diagnosis? Malar J. 2007;6(58):doi: 10.1186/1475-2875-6-58.
21. Kyabayinze D, Tibenderana J, Odong G, Rwakimari J, Counihan H.
Operational accuracy and comparative persistent antigenicity of HRP2 rapid
diagnostic tests for Plasmodium falciparum malaria in a hyperendemic
region of Uganda. Malar J. 2008;29(7):221–31.
22. Laursen J, Dalskov S-M, Damsgaard C, Ritz C. Back-transformation of
treatment differences - an approximate method. Eur J Clin Nutr.
2014;68:277–80.
23. Fabiansen C, Phelan K, Cichon B, Ritz C, Briend A, Michaelsen K, et al. Short
children with a low midupper arm circumference respond to food
supplementation: an observational study from Burkina Faso. Am J Clin Nutr.
2016;103:415–21.
24. Bjornstad E, Preidis G, Lufesi N, Olson D, Kamthunzi P, Hosseinipour M, et al.
Determining the quality of IMCI pneumonia care in Malawian children.
Paediatr Int Child Health. 2014;34(1):29–36.
25. Perkins B, Zucker J, Otieno J, Jafari H, Paxton L, Redd S, et al. Evaluation
of an algorithm for integrated management of childhood illness in an
area of Kenya with high malaria transmission. Bull World Health Organ.
1997;75(1):33–42.
26. Ministere de la Sante, Burkina Faso. Protocole national: Prise en charge
integree de la malnutrition aigue. Burkina Faso: Ministere de la Sante; 2014.
27. Thurnham D, McCabe G. Influence of infection and inflammation on
biomarkers of nutritional status with an emphasis on Vitamin A and Iron. In:
Priorities in the assessment of vitamin A and iron status in populations,
Panama City, Panama, 15-17 September 2010. Geneva: World Health
Organisation; 2012.
28. Manesh A, Sheldon T, Pickett K, Carr-Hill R. Accuracy of child morbidity data
in demographic and health surveys. Int J Epidemiol. 2008;37:194–200.
29. Coughlin SS. Recall bias in epidemiologic studies. J Clin Epidemimiology.
1990;43(1):87–91.
30. Das J, Hammer J, Sanchez-Paramo C. The impact of recall periods on
reported morbidity and health seeking behaviour. J Dev Econ.
2012;98:76–88.
31. Chen I, Clarke S, Gosling R, Hamainza B, Killeen G, Magill A, et al.
“Asymptomatic” malaria: A chronic and debilitating infection that
should be treated. PloS Med. 2016;doi:10.1371/journal.pmed.1001942.
32. Franks S, Koram K, Wagner G, Tetteh K, McGuiness D, Wheeler J, et al.
Frequent and persistent, asymptomatic plasmodium falciparum infections
in african infants, characterised by multilocus genotyping. J Infect Dis.
2001;183:796–804.
33. Reeds P, Fjeld C, Jahoor F. Do the differences between amino acid
compositions of acute-phase and muscle proteins have a bearing on
nitrigen loss in traumatic states? J Nutr. 1994;124:906–10.
Cichon et al. BMC Nutrition  (2016) 2:57 Page 9 of 10
34. Mwangome M, Fegan G, Prentice A, Berkley J. Are diagnostic criteria for
acute malnutrition affected by hydration status in hospitalised children? A
repeated measures study. Nutr J. 2011;10(92):doi:10.1186/1475-2891-10-92.
35. Crane R, Jones K, Berkley J. Environment enteric dysfunction: An overview.
Food Nutr Bull. 2015;36(1):76–87.
36. Prendergast A, Humphrey J. The stunting syndrome in developing
countries. Paediatr Int Child Health. 2014;34(4):250–65.
37. Prendergast A, Humphrey J, Mutasa K, Majo F, Rukobo S, Govha M, et al.
Assessment of environmental enteric dysfunction in the SHINE trial:
Methods and challenges. Clin Infect Dis. 2015;61(S7):S726–32.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Cichon et al. BMC Nutrition  (2016) 2:57 Page 10 of 10
